IP Library Granted Patent US 12,612,655
Granted Patent B2
US 12,612,655 · App. 17/384,390 · Granted Apr 28, 2026

Methods for screening biological samples for contamination

Inventors: Walid Korani (Madison, AL); Nader Deeb (Navasota, TX); Alan Mileham (Middleton, WI); Charles Michael Cowan (Middleton, WI)
Assignee: Inguran, LLC
C12Q1/6816C12Q1/6806C12Q1/6827G16B30/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,612,655
App. No.
17/384,390
Granted
Apr 28, 2026
Kind
B2
Abstract

The invention includes a method of screening a biological sample for contamination by sequencing a first biological sample at a first depth to generate a first nucleotide sequence; determining map coordinates for one or more homozygous loci in the first nucleotide sequence; sequencing a second biological sample at a second depth to generate a second nucleotide sequence, wherein the second depth is lower than the first depth; determining loci in the second nucleotide sequence at the determined map coordinates; and comparing the one or more homozygous loci in the first nucleotide sequence with the determined loci in the second nucleotide sequence.

Claims (39)

1 . A method of screening a biological sample for contamination comprising:

sequencing a first biological sample at a first depth to generate a first nucleotide sequence;

determining map coordinates for one or more high confidence homozygous loci (HCHL) in the first nucleotide sequence;

sequencing a second biological sample at a second depth to generate a second nucleotide sequence, wherein the second depth is lower than the first depth;

identifying a nucleotide in the second nucleotide sequence at the determined map coordinates; and

comparing a nucleotide in the one or more HCHL in the first nucleotide sequence with the identified nucleotide in the second nucleotide sequence.

2 . The method of claim 1 , further comprising the step of detecting a mismatch between the nucleotide in the one or more HCHL in the first nucleotide sequence and the identified nucleotide in the second nucleotide sequence.

3 . The method of claim 2 , further comprising the step of discarding the second biological sample based on the mismatch.

4 . The method of claim 1 , further comprising the steps of

detecting a match between the nucleotide in the one or more HCHL in the first nucleotide sequence and the identified nucleotide in the second nucleotide sequence; and

further processing the second biological sample based on the match.

5 . The method of claim 4 , wherein the second biological sample comprises a sperm cell sample and wherein the step of further processing the second biological sample comprises sex-sorting the second biological sample, ablating sperm cells bearing an undesired sex chromosome in the second biological sample or cryopreserving sperm cells in the second biological sample.

6 . The method of claim 1 , wherein the first biological sample comprises a pure biological sample.

7 . The method of claim 6 , wherein the second biological sample comprises a test biological sample.

8 . A method of screening a biological sample for contamination comprising:

sequencing a first biological sample at a first depth to generate a first nucleotide sequence;

determining map coordinates for one or more high confidence homozygous loci (HCHL) in the first nucleotide sequence;

sequencing a second biological sample at a second depth to generate a second nucleotide sequence, wherein the second depth is lower than the first depth;

sequencing at least one replicate of the first biological sample at the second depth to generate a third nucleotide sequence;

identifying a nucleotide in the second nucleotide sequence at the determined map coordinates and a nucleotide in the third nucleotide sequence at the determined map coordinates; and

comparing a nucleotide in the one or more HCHL in the first nucleotide sequence with i) the identified nucleotide in the second nucleotide sequence and ii) the identified nucleotide in the third nucleotide sequence.

9 . The method of claim 8 , wherein the step of identifying a nucleotide in the second nucleotide sequence at the determined map coordinates and a nucleotide in the third nucleotide sequence at the determined map coordinates comprises

generating read data from the second nucleotide sequence and read data from the third nucleotide sequence; and

mapping the read data from the second nucleotide sequence and the read data from the third nucleotide sequence.

10 . The method of claim 8 , further comprising the step of detecting a mismatch between the nucleotide in the one or more HCHL in the first nucleotide sequence and i) the identified nucleotide in the second nucleotide sequence or ii) the identified nucleotide in the third nucleotide sequence.

11 . The method of claim 10 , further comprising the step of discarding the second biological sample based on the mismatch.

12 . The method of claim 8 , further comprising the steps of

detecting a match between the nucleotide in the one or more HCHL in the first nucleotide sequence and i) the identified nucleotide in the second nucleotide sequence or ii) the identified nucleotide in the third nucleotide sequence; and

further processing the second biological sample based on the match.

13 . The method of claim 12 , wherein the second biological sample comprises a sperm cell sample and wherein the step of further processing the second biological sample comprises sex-sorting the second biological sample, ablating sperm cells bearing an undesired sex chromosome in the second biological sample or cryopreserving sperm cells in the second biological sample.

14 . The method of claim 8 , wherein the first biological sample comprises a pure biological sample.

15 . The method of claim 14 , wherein the second biological sample comprises a test biological sample.

16 . The method of claim 8 , wherein the at least one replicate comprises a biological replicate.

17 . The method of claim 16 , wherein the biological replicate comprises a portion of a pure biological sample.

18 . A method of screening a biological sample for contamination comprising:

determining or imputing a first nucleotide sequence for a first biological sample and a second nucleotide sequence for a second biological sample, the first biological sample and the second biological sample being from the same individual of a species;

identifying matched and mismatched high confidence homozygous loci (HCHL) between the first nucleotide sequence and the second nucleotide sequence;

determining a matched HCHL count and a mismatched HCHL count from the identified matched and mismatched HCHL, wherein a sum of the matched HCHL count and the mismatched HCHL count constitutes a total HCHL count;

calculating a ratio of the matched HCHL count to the total HCHL count or a ratio of the mismatched HCHL count to the total HCHL count.

Assignments (4)
SECURITY INTEREST Recorded Nov 24, 2025
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073783/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2022
From: GENETIC VISIONS-ST, LLC
To: INGURAN, LLC
Reel/Frame 060793/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2022
From: MILEHAM, ALAN; COWAN, CHARLES MICHAEL
To: GENETIC VISIONS-ST, LLC
Reel/Frame 060688/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2022
From: KORANI, WALID; DEEB, NADER
To: INGURAN, LLC
Reel/Frame 060688/0587 →
Continuity (2)
Provisional Application 63056287 · Jul 24, 2020
Related Publication 20220025443A1 · Jan 27, 2022
References Cited (17)
US 10262755B2 · Babiarz et al. · 2019 [cited by applicant]
US 20150197785A1 · Carter et al. · 2015 [cited by applicant]
US 20170275629A1 · Lieberman · 2017 [cited by examiner]
US 20170275692A1 · Moreno · 2017 [cited by examiner]
US 20180237838A1 · Sakarya et al. · 2018 [cited by applicant]
US 20190010543A1 · Babiarz · 2019 [cited by examiner]
US 20200157629A1 · Babiarz et al. · 2020 [cited by applicant]
CN 110444255A · 2019 [cited by examiner]
International Search Report And Written Opinion issued on Feb. 4, 2022 in related Appl. No. PCT/UA21/43027. [cited by applicant]
Ion Torrent Amplicon Sequencing. Life Technologies Corporation. 2011. [cited by applicant]
Weber-Lehmann et al. “Finding The Needle in The Haystack: Differentiating “Identical” Twins In Paternity Testing And Forensics By Ultra-Deep Next Generation Sequencing.” Forensic Science International: Genetics, vol. 9,… [cited by applicant]
Kiessling et al. “Detection and Identification of Bacterial DNA In Semen.” Fertility and Sterility, vol. 90, No. 5, Nov. 2008. pp. 1744-1756. [cited by applicant]
Jenkins et al. “Pre-Screening Method for Somatic Cell Contamination in Human Sperm Epigenetic Studies.” Systems Biology in Reproductive Medicine. vol. 64, No. 2, 2018, pp. 146-155. [cited by applicant]
European Search Report and Written Opinion issued Aug. 6, 2024, in related EP Appl No. 21846199.4, filed on Jan. 19, 2023. [cited by applicant]
Office Action issued in counterpart New Zealand Application No. 796204, dated Sep. 23, 2025 (4 pages). [cited by applicant]
Office Action issued in counterpart Canadian Application No. 3189334, dated Oct. 3, 2025 (4 pages). [cited by applicant]
Xu, C., Wu, K., Zhang, J., Shen, H., & Deng, H. (2016). Low-, high-coverage, and two-stage DNA sequencing in the design of the genetic association study. Genetic Epidemiology, 41(3), 187-197. https://doi.org/10.1002/gep… [cited by applicant]